The nucleotide sequence of two restriction fragments located in the gene AB region of bacteriophage S13. by Grosveld, F.G. (Frank) & Spencer, J.H.
Nucleic Acids ResearchVolume 4 Number 7 July 1977
The nucleotide sequence of two restriction fragments located in the gene AB region of
bacteriophage S13
Frank G. Grosveld and John H. Spencer
Department of Biochemistry, McGill University, 3655 Drummond Street, Montreal, Quebec
H3G 1 Y6, Canada
Received 22 April 1977
ABSTRACT
The nucleotide sequence of a double stranded DNA fragment from the
gene AB region of bacteriophage S13 DNA has been determined. The fragment
was isolated as two adjacent shorter fragments by cleavage of S13 replica-
tive form (RF) DNA with restriction endonuclease III from Hemophilus
aegyptius. The strands of the fragments were separated electrophoretically
and hydrolyzed with T4 endonuclease IV to yield short oligonucleotides
which were then sequenced by partial exonuclease digestion. The complete
nucleotide sequence of the restriction fragments was obtained by ordering
the inter- and intrastrand overlapping oligonucleotide sequences. The
adjacent fragments were 190 nucleotides in length. The sequences included a
HindII site, an AluI site and two sequences which may be possible transcrip-
tion initiation sequences, one with an adjacent sequence homologous to the
canonical promoter site sequence T-A-T-Pu-A-T-Pu. Examination of the three
possible reading frames for translation of the sequence revealed only one
possible complete translation product. The postulated partial sequence of
gene A protein has a highly positively charged arginine-rich area which
may have importance in DNA binding.
INTRODUCTION
Bacteriophages S13 and OX174 are almost identical in size, physical
and biological characteristics. The two phages are closely related in
biological function as demonstrated by the criteria of serological cross-
reaction1 and genetic recombination2 Complementation tests have shown
that they have eight homologous genes3 and the genes occur in the same
order4'5. Comparative studies of the two phage DNA's by pyrimidine
cluster6 and restriction endonuclease7,8,9 analyses indicate extensive
sequence homology. Most of the longer pyrimidine oligonucleotides in the
two DNA's have identical sequences6, and the various restriction enzyme
maps are very similar
.
The gene products of five of the genes of the
two phages comigrate on SDS polyacrylamide gels and are assumed to be
almost identical in size10. Gene D and H proteins from each phage have
similar yet different electrophoretic mobilities but the gene B proteins
differ markedly and Tessman et aZ.10 have concluded that the gene B protein
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of S13 is considerably smaller than that of *X174. In a study of the
in vitro transcripts of 4X174 DNA and their hybridization to various
restriction fragments, Smith and Sinsheimer have placed the start of
in vitro RNA transcription of gene B in restriction fragment 4X174 HindIII8.
The gene AB regions of the S13 and OX174 genomes thus have a good
potential for providing information on the control of transcription and
translation in the two phages. This report presents the nucleotide seque-
nce of S13 restriction enzyme fragments HaeIII 8 and 9 which are located
in the gene AB region and which correspond to the junction of 4X174
fragments HindIII 3 and HindIlII 8 and include most of 4X174 HindIII 8.
MATERIALS AND METHODS
Chemicals. Ethidium bromide was purchased from Sigma Chemical Co. and
optical grade CsCl from the Harshaw Chemical Co. DEAE Sephadex A-25 was
obtained from Pharmacia (Canada) Ltd, Bio-Gel A from Bio-Rad Laboratories
and H 32PO from NEN (Canada) Ltd. [y-32P]ATP was prepared as described3 12by Schendel and Wells . Reagents for electrophoresis, acrylamide and bis
(N,N'-methylene-bis (acrylamide)) were Eastman products. DEAE-cellulose
and cellulose for thin-layer chromatography were products of Macherey,
Nagel and Co., purchased from Brinkmann Instruments (Canada) Ltd. Cellulose
acetate strips were purchased from Schleicher and Schuell Inc., Keene,N.H.,
and cellogel strips (manufactured by Chemtron, Milan, Italy) from Mandel
Scientific Co.
Enzymes. Snake venom phosphodiesterase and bacterial alkaline phospha-
tase (electrophoretically pure) were obtained from ICN (Canada) Ltd.
Alkaline phosphatase was heat treated to remove phosphodiesterases1, snake
venom phosphodiesterase was pretreated at 370C for 3 hr at pH 3.6 to remove
145' nucleotidase activity . Pancreatic deoxyribonuclease A was purified as
described by Junowicz and Spencer 5 and exonuclease I according to Lehman
16
and Nussbaum
. Polynucleotide kinase and T4 endonuclease IV were prepared
T4m817from Escherichia coZi B infected with bacteriophage T4amN82. Polynucleo-
tide kinase was isolated according to Richardson18 with the modifications
described by Harbers et aZ.6
T4 endonuclease IV was isolated by the method described by Sadowski
and Bakyta19 up to the first phosphocellulose column fractionation step.
Each fraction from the phosphocellulose column was assayed for the presence
of T4 endonuclease IV using radioactively labeled (32P or 3H) S13 DNA as
substrate in the presence of exonuclease I, essentially as described by
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Sadowski and Bakyta19. The fractions that contained T4 endonuclease IV
activity were then assayed again using the same substrate but incubation
was for 30-40 minutes instead of 10 minutes and exonuclease I was omitted
from the reaction mixture. This assay modification located those fractions
containing endogenous 3' exonuclease activity. The exonuclease activity was
found in the last third of the fractions with T4 endonuclease IV activity
eluted from the phosphocellulose column. The T4 endonuclease IV fractions
containing little or no 3' exonuclease activity were further purified by
19DEAE-cellulose chromatography as described by Sadowski and Bakyta . The
fractions which did not adhere to the DEAE cellulose column were then
refractionated twice on phosphocellulose. The T4 endonuclease IV prepara-
tion from the last phosphocellulose column, when assayed by the 'minus'
exonuclease I assay described above showed a definite lag before the appear-
ance of acid soluble radioactivity. This was taken as a strong indication
of little or no 3' exonuclease contamination in the preparation. The prepa-
ration was dialyzed against 50 mM Tris-HCl buffer (pH 7.6) in 50% glycerol
and stored at -20°C.
Restriction endonuclease HaeIII was isolated from HemophiZus
aegyptius (ATCC strain IIII6) by the method of Smith and Wilcox20 with the
modifications described previously7.
Preparation and isolation of restriction fragments of S13 DNA. Purifica-
tion of 32P-labeled bacteriophage S13 replicative form DNA (RF DNA) was
performed as described by Schekman et aZ. 21up to the phenol extraction and
isopropanol precipitation step. The precipitated material was then
dissolved in 50 mM Tris-HCl, 20 mM EDTA (pH 8.0) and applied to a Bio-Gel
A-15m column which was eluted with the same buffer. The void volume
containing the1 S13 RF DNA was collected and RF I DNA separated from RF II
DNA by centrifugation in a CsCl, ethidium bromide gradient. The purifica-
tion was completed as described by Grosveld et aZ.7 The Bio-Gel column
modification replaced the sucrose gradient step in the original procedure.
Digestion of S13 RF DNA with restriction endonuclease HaeIII was as
described by Middleton et aZ.22
Gel electrophoresis of restriction fragments was performed as
described elsewhere7. The separated restriction fragments were eluted from
gels by soaking the crushed gel fragments in 0.6 M NaCl for at least 4
hours at 0°C. The extracted gel was removed by filtration through a fine
grade sintered glass filter. The fragment extract was applied to a column
of hydroxyapatite (1 x 1 cm) which was washed with 0.1 M potassium phos-
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phate buffer (pH 7.0), then eluted with l.OM potassium phosphate buffer
(pH 7.0). The restriction fragments were desalted by adsorption to DEAE-
cellulose, eluted with 1.0 M triethylammonium bicarbonate (TEAB), pH 8.0,
and repeatedly evaporated to dryness.
Depurination of restriction fragments. The isolated restriction frag-
ments were hydrolyzed with 2% diphenylamine in 67% formic acid at 30°C for
18 hr23. The hydrolysate was extracted three times with ether, dried and
fractionated by ionophoresis-homochromatography24, as modified for
25pyrimidine oligonucleotides
Strand separation and T4 endonuclease IV hydrolysis. The solution of
restriction fragments chosen for sequence analysis was heated at 1000C for
2 min and applied directly to a cellogel strip. Electrophoresis conditions
6
were identical to those for oligonucleotide separation
.
The restriction
fragment strands (4-6 pg) were eluted from the strips, dried, and dissolved
in 50 pl water. Twenty p1 of 0.1 M Tris-HCl buffer (pH 8.5) containing
50 mM MgCl2 and 25 mM mercaptoethanol were added, followed by 20-30 pl of
T4 endonuclease IV (20-30 units). The mixture was incubated at 370 or 450
for 12 hrs. The reaction was stopped by adsorption of the oligonucleotides
to DEAE-Sephadex A-25, elution by 1.0 M TEAB (pH 8.0) and evaporation of
the eluate to dryness.
5'_32P-Terminal labeling of T4 endonuclease IV oligonucleotides. The oligo-
nucleotides released by T4 endonuclease IV were incubated with 20 pg of
alkaline phosphatase in 100 pl of 50 mM Tris-HCl, 10 mM MgCl2 buffer
(pH 8.9) at 55% for 1 hr. The alkaline phosphatase was inactivated by
treatment with alkali26, the neutralized solution transfered to a tube
containing 108 dpm of dried [y-32P]ATP, and 20 p1 of polynucleotide kinase
(0.01 units) and 1 pl of 1.4 M a-mercaptoethanol added. The reaction mix-
ture was incubated for 2 hrs at 37°C, then applied directly to a 1 x 0.5 cm
DEAE-Sephadex A-25 column. The excess ATP was eluted with 0.2 M TEAB
(pH 8.0), the 5'-labeled oligonucleotides eluted with 1.3 M TEAB, collected
and evaporated to dryness.
Fractionation of T4 endonuclease IV oligonucleotides. The 5' 32P-labeled
24
oligonucleotides were separated by ionophoresis-homochromatography as
described in detail elsewhere for pyrimidine oligonucleotides6 except that
the DEAE-cellulose plates were 20 x 40 cm and the eluate a 2% solution of
27yeast RNA partially degraded by alkali for 12 hours
5' 32P-labeled oligonucleotides separated by ionophoresis-
homochromatography were visualized by radioautography, the spots were
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scraped from the thin layer plate and the oligonucleotides eluted with
1.0 M TEAB (pH 8.0) and evaporated to dryness.
Partial digestion of oligonucleotides with snake venom phosphodiesterase.
25This was performed as described by Ling . The hydrolysis products were
separated by ionophoresis-homochromatography24'6 and the oligonucleotides
visualized by radioautography.
RESULTS
Since the sequence methods to be used were dependent on the measure-
ment of a 5' 32P-terminal label the specificity, exonucleolytic and phos-
phatase activities of the T4 endonuclease IV preparations were investigated.
To determine the specificity of hydrolysis, S13 DNA was degraded with T4
endonuclease IV, the resulting oligonucleotides 5' 32P-labeled then
hydrolyzed to 5' mononucleotides. Separation of the 5' mononucleotides
is shown in Fig. la. More than 95% of the 32P label occurred in the
Figure 1
T G C A (a) 5' terminal nucleotide analysis
, v v , of the oligonucleotides released by
T4 endonuclease IV. The oligonucle-
1.5 otids were 5'32P-labeled with
[y- 'P]ATP and polynucleotide
I0Ikinase. Excess ATP was removed
chromatography on Sephadex G-254
and the oligonucleotides degraded to
5' mononucleotides with DNase and
snake venom phosphodiesterase1 . The
A
I 45' mononucleotides were separated byNo Dowex-50 chromatography29.b. 10 20 30 40 (b) Sephadex G-25 chromatography of
IE oligonucleotides released by T4
*0lo Aendonuclease IV.(c) Sephadex G-25 chromatography of
oligonucleotides released by T4
endonuclease IV redigested with T4
endonuclease IV.1. S 10 15 20 25
'10-
S 10 15 20 25
FRACTION NUMBER
cytidylic acid fraction indicating that the T4 endonuclease IV preparation
is highly specific in producing oligonucleotides with a 5' terminal C
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residue. The 3' terminal specificity was deduced from the sequence
analyses (see Discussion). To test the enzyme preparation for exonuclease
and phosphatase activity, 5' 32P-labeled T4 endonuclease IV oligonucleo-
tides were redigested with T4 endonuclease IV, the enzyme inactivated by
heat denaturation for 3 min at 1000C and the mixture chromatographed on
Sephadex G-25 (Fig. lc). The contro-l experiment prior to redigestion with
T4 endonuclease IV is shown in Fig. lb. Comparison of the results shows a
slight shift of 32P label into shorter oligonucleotides based on the
broadening of the larger peak (fractions 10-17). There was no change in
the amount of label in fractions 18-25 relative to that in fractions 10 to
17 in either experiment. This indicates that the T4 endonuclease IV prepa-
ration was essentially free of phosphatase and exonuclease activity.
Hydrolysis of uniformly 32P-labeled S13 DNA with T4 endonuclease IV in the
'minus' exonuclease I assay (see Methods) did indicate the presence of a
very small amount of 3' exonuclease activity.
Strand separation of fragments HaeIII 8 and 9 and identification of strand
polarity. The separation of uniformly 32P-labeled strands of fragments
HaeIII 8 and 9 by electrophoresis on cellogel strips is shown in Figure 2.
+ve r-
rr_. Figure 2. Radioautograms
r. r of the strand separations
of HaeIII 8 and 9 on cello-
Hae8v _ gel strips.
Hae9v- r indicates the positions
Hae8c of red marker dyes, v viral
and c, complementary
strands. Electrophoresis
was for 90 mins, migration
was approximately 20 to 25
Hae9c- #L. - cms from the origin.
-ve
To determine which strands were viral and which complementary in origin,
they were eluted from the cellogel and hybridized to S13 viral DNA. The
hybridization mixtures were fractionated on Bio-Gel A-15m columns. The
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chromatographic profiles presented in Fig. 3 show that the electrophoreti-
cally slower moving strands of both HaeIII 8 and 9 were eluted in the void
volume having hybridized to the viral DNA, while the electrophoretically
faster moving strands were retained on the column. Thus the slower moving
strands are complementary strand in origin, and the faster moving strands
viral.
Figure 3. Hybridization of
a. C. the JZP-labeled separated
strands of HaeIII 8 and 9
v v to viral S13 DNA.I; Each of the separated
2- flL 2 2 -2 strand preparations was mix-
ed with 200 pg of S13 DNA|'.4t '' ; and hybridized for 36 hrs
*1-l1 lo 1- ' i A -1 at 600C in a volume of 200
o IX pl of 3 x SSC. The mixtures
XE E were applied to a 15 ml Bio-
_L_;Nez-4w t!""=: o Gel A-15m column and eluted
w b. 10 20 A- d. 10 20 N with 3 x SSC. a) HaeIII 8
C4 nslow strand, b) HaeIII 8X
~v v fast strand, c) HaeIII 9
2- -2 2- s _ slow strand, d) HaeIII 9
2 2 2
-
2 fast strand. o- 32P-label
of the separated strands;Il inl.' rl "---. , absorbance at1 : L 1 1 * S 1 260 nm of the viral DNA.
0 10 20 0 10 20
FRACTION NUMBER
Sequence analysis of oligonucleotides released by T4 endonuclease IV.
Fig. 4 shows radioautograms of ionophoretic-homochromatographic separations
of some of the 5' 32P-labeled oligonucleotides released by T4 endonuclease
IV from the separated strands of HaeIII 9. The patterns show the divergen-
ces expected from products derived from separated DNA strands and indicate
that strand separation is adequate since there is no obvious cross
contamination. There were minor differences only in fingerprint patterns of
degradations performed at 37°C compared to ones at 45OC30 with no obvious
shifts from longer to shorter oligonucleotides. Incubations at both
temperatures were used to obtain oligonucleotides for sequence analyses.
The separated 5'-32P-labeled oligonucleotides were scraped from the TLC
plates, each partially degraded with snake venom phosphodiesterase and the
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products separated by ionophoresis-homochromatography. Radioautographs of
some of the partial digest separations are shown in Fig. 5. The successive
loss of nucleotides from the 3' end of an oligonucleotide results in a
chromatographic fingerprint with characteristic differences in angles and
distances between the particular oligonucleotide spots, dependent on the
3' terminal base which has been removed31'32. In general the nucleotides
A B
134
133
132
Has 9 virkal #trnd
F 139
138
I IfX"I
144
153
152 I
150 *
148
7
146
i145
I XII.w|s. ....
Nsa 0 compl. strand
Figure 4. Radioautograms of two dimensional separations of the oligo-
nucleotides released by T4 endonuclease IV from (a) viral and (b) comple-
mentary strands of HaeIII 9. The dotted circles indicate the yellow dye
marker. Dimension I, electrophoresis; Dimension II, homochromatography.
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Figure 5. Radioautograms of two
dimensional separations of partial
snake venom digests of T4
endonuclease IV oligonucleotides.
a) oligonucleotide 07
b) oligonucleotide 139
c) oligonucleotide 02.
The dotted circles indicate the
blue dye markers. Dimension I,
electrophoresis, Dimension II,
homochromatography.
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in the middle of a sequence (4-15 nucleotides in length) were easily
identified according to rules and calculations described by others31,32
However at the 3' end of long oligonucleotides, especially those rich in
G and T, there were difficulties in distinguishing between a loss of an
A versus a G. At the 5' end where the oligonucleotides have been reduced
to short chain lengths, especially when the remainder of the oligonucleo-
tide contains few or no T's or G's, the angles and distances for the loss
of a C or an A do not follow the normal patterns of shifts to the left,
but instead are to the right. The latter problem was not a major one in
the present study since the restriction enzyme fragments used terminate in
5'C, the HaeIII cleavage site being 5'. . .G-G-C-C...33 , and the oligonu-
cleotides released by T4 endonuclease IV all end in 5' C also.
When a sequence assignment was ambiguous (A or G, C or A, G or T)
it was resolved from the overlapping sequence from the opposite strand or
from another partial product from the same strand. Fig. 5a shows the
fingerprint of oligonucleotide 07 with the sequence 5' C-A-T_C-G-C-A-G-T-G
T 3' which has a T or G ambiguity in the third position from the 5' end.
This was resolved with the overlapping sequences in oligonucleotide 139
from the same strand (sequence 5' C-C-C-A-T-C-G 3', Fig. Sb) and oligo-
nucleotide 02 from the complementary strand (sequence 5' C-G-A-T-G-G-G-C-
A-T-A 3', Fig. 5c). The ambiguous position is a T giving the total
sequence:
139
07
5' C-C-C-A-T-C-G-C-A-G-T-T 3'
3' A-T-A-C-G-G-G-T-A-G-C 5'
02
The sequences of the oligonucleotides shown in Fig. 4 and 5 and
from other T4 endonuclease IV digests are listed in Table 1. The sequences
were ordered on the basis of overlaps, resulting in the total sequence for
HaeIII 8 and 9 as shown in Fig. 6. The 5' terminal sequences of each
restriction enzyme fragment were confirmed separately by 5'32P-labeling of
the separated strands with [y-32P]ATP and polynucleotide kinase, followed
by degradation with T4 endonuclease IV. The few resulting 32P-terminally
labeled oligonucleotides were all from the 5' termini and shown to have
the sequences corresponding to HaeIII 9 viral strand oligonucleotides 06,
34 and 134, HaeIII 8 complementary strand oligonucleotides 14, and 119 and
viral strand oligonucleotides 7, 12, 111 and 115 (see Table 1). Further
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Table 1 Sequences of the oligonucleotides released by T4 endonuclease IV
from the viral and complementary strands of S13 HaeIII 8 and 9.
HaeIII 8 viral strand oligonucleotides
1. ------T-G-C-A-T-T-T-T-A-T-G
2 & 103. C-G-C-C-G-C-C-A-G-T-T-A-A-A-T-A-G
3 & 107. C-A-G-G-T-A-G-C-G-T-T-G-A
3. C-A-T-T-T-T-A-T-G-C-G-G-A
4 & 104. ------C-A-T-T-T-T-A-T-G
5 & 109. C-G-G-G-T-A-C-G-C-A-A-T
6. C-A-G-G-T-A-G-C-G-T-T-G
7. C-C-G-T-C-T-T-C-A-T-T-T
8. C-A-A-A-A-T-A-C-G
9 & 112. C-T-T-T-G-G-T-C-G-T
10 & 113. C-G-G-G-T-A-C-G
11 & 114. C-A-C-T-T-C-C-T-T
12 & 115. C-C-G-T-C-T-T
13a. C-G-G-T-G
105. C-A-C-T-T-C-C-T-T-C-A-G-G-T-A-G
106. C-C-C-T-A-A-C-T-T-T-G-G-T-C-G-T
108. C-A-A-A-A-T-A-C-G-T-G-G
110. C-A-A-A-A-T-A-C-G-T-G
C-G-T-T-G-A-C-C-C-T-A-A
111. C-C-G-T-C-T-T-C-A-T-T-T-C
HaeIII 9 viral strand oligonucleotides
32. C-A-C-G-T-T-C-T-G-G-T-T-G-G
33 & 133 & 05. C-A-G-G-A-C-G-C-T-T-T-T-T
34 & 134 & 06. C-C-T-T-A-T-G-G-T-T-A
35 & 135 & 07. C-A-T-C-G-C-A-G-T-T
36 & 136. C-A-G-T-A-T-G-C-C
37 & 137 & 09. C-A-G-T-A-T-G
37 & 137 & 09. C-A-G-T-T-C-G
39 & 138 & 08. C-T-A-C-A-C-G
139. C-C-C-A-T-C-G
132. C-C-T-T-A-T-G-G-T-T-A-C-A-G-T-A-T-G
140. C-A-G-G-A-C-G
HaeIII 8 complementary strand oligonucleotides
14 & 119. C-C-A-C-G-T-A-T-T-T-T-G-C-A-A-G
15. C-G-C-T-A-C-C-T-G-A-A-G-G--A-A
16 & 120. C-T-A-T-T-T-A-A-C-T-G-G-C-G-G
17. C-C-A-C-G-T-A-T-T-T-T-G-C-A-A
C-A-T-G-G-A-A-A-T-G-A-A-G-A
18. C-A-C-C-G-C-A-T-G-G-A-A-A-T
C-G-A-C-G-A-C-C-A-A-A-G-T-T
19. C-G-T-A-T-T-T-T-G-C-A-A-G
20 & 121. C-C-G-C-A-T-A-A-A-A-T-G
21 & 123. C-C-A-C-G-T-A-T-T-T-T-G
22. C-C-G-C-A-T-A-A-A-A-T
23. C-G-A-T-T-G-C-G-T-A
24. C-A-T-A-A-A-A-T-G
25. C-G-A-T-T-G-C-G-T
26 & 126. C-C-C-G-A-C-G-A
27. C-G-T-A-T-T-T-T-G
28 & 127. C-T-A-T-T-T-A-A
28 & 127. C-T-G-G-C-G-G
29 & 128. C-G-A-C-G-A-C
31. C-G-T-A-C-C
122. C-G-A-T-T-G-C-G-T-A-C-C-C-G
124. C-G-A-T-T-G-C-G-T-A
HaeIII 9 complementary strand oligonucleotides
41 & 143. C-A-G-A-A-C-G-T-G-A-A-A-A-A-G-C-G-T
42. C-C-T-G-C-G-T-G-T-A-G-C-G-A-A
43. C-A-G-A-A-C-G-T-G-A-A-A-A-A
47. C-T-G-T-A-A-C-C-A
48 & 153. C-A-C-A-A-C-C-A-A
49 & 152 & 03. C-A-A-C-C-A-A-C
50 & 153 & 04. C-A-A-C-C-A-A
52. C-G-A-T-G-G-G-C
53. C-T-G-T-A-A-C
144. ---------T-A-G-C-G-A-A-C-T-G
147 & 01. C-T-G-T-A-A-C-C-A-T-A-A-G-G
149 & 02. C-G-A-T-G-G-G-C-A-T-A
The numbers 01 to 09, 1 to 53 and 103 to 153 refer to oligonucleo-
tides from three different experiments. The underlined sequences are the
5' termini (see text). Sequences without a number are minor sequences
present together with the sequence directly above.
confirmation of the sequence was by pyrimidine tract analyses. Radioauto-
grams of uniformly 32P-labeled pyrimidine oligonucleotides released by
formic acid diphenylamine hydrolysis of fragments HaeIII 8 and 9 and
separated by ionophoresis-homochromatography are shown in Fig. 7a, b. The
longest pyrimidine oligonucleotide present in HaeIII 8 is C4T4 (nucleo-
tides 38-45) and in HaeIII 9, C2T5 (nucleotides 165-171).
The total sequence (Fig. 6) has two sequence assignments based on
assumptions due to lack of satisfactory overlaps. Base 34 is the 5' end C
in the complementary strand sequences of oligonucleotides 20, 22 and 121,
while base 36.is the 5' end C of the viral strand oligonucleotides 11, 105
and 114. Since the first two bases at the 3' end of oligonucleotide 15
(complementary strand) could not be assigned with certainty, the only
evidence for A in position 35 is provided by a minor sequence in oligonu-
2246
Nucleic Acids Research
,CD
F-
F-
1CD
r-l U1) LDt
-<
LO
CO)
CD
I U
l-l
Do
.iF-CD
CMF-F- OCM 0CDC%J F-( C)
F-
FC
CD
CO u
I u
CO)
*V0
CD C tD
LO .O
o cm0
CD m
CO U50(E
C - -o
Xz7I
*
.
fl
_ F
_
L -_[!
C'
Coj1-
IIC
A
0CDIr-
CM
IF-
lCDU
UL)VCD)
U
C
Cs
J 1-_
I-
Cki
qr)
.] ]C1 L1
I lO
CIcJ
COC\JC-
cM
"- r-
o Io
m~- LO
CMJ
li-
UC-)
JCDj
L.)
CD
CD)
CD )
CD
U
CD
CD)
CDJ
CD 1
< -
<
cc
CD
CDI
F-
CD
F-
cc
C-
cc
ccZ
CD a
Hl 0)
cc
dr-I
W -P4-u)
s.
av -
CO,
E-0
a)
UM w
U 0
'C
0)0)
.C.C
F- C
a)
* I-
~0
-IC
4a)
4.) 4.
4 0
C 4.00a*,-)
C4oUo
0 >0 _ 0)
a) >
cr_0U0)
sU)O
_I
5.O0_O*0-.-w
N'.. I )I
2246
o
Nucleic Acids Research
A Haem8
/ P1../
_& .CTp :.
"W
....+~
CT3 0WC2T3
C
a4.. C2
T 3
C3T
Ok C4T4
I
B HaeM9
P.-
::
CT tF-~~C2
C3
CT3
215 ii
Figure 7. Radioautograms of pyrimidine
b) HaeIII 9. Pi is inorganic phosphate.
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cleotide 3 with the 3' end sequence ---C-G-G-A 3'. Since the 3' end of A
must be next to a C (due to the specificity of T4 endonuclease IV) the
following assignment was made (see also Fig. 6):
3 minor 11-105-114
5' ------T-T-T-A-T-G-C-G-G-A-C-A-C-T-T-C-C-T-T-------3'
30 40
3' ------A-A-A-T-A-C-G-C-C,,T-G-T-G-A-A-G-G-A-A-------5'
20-22-121 15
The other uncertain sequence occurs at bases 102 and 103 where both strands
contain the dinucleotide -G-C- which resulted in cleavage without satisfac-
tory overlaps. However since this particular situation involving lack of
overlaps at dinucleotide -G-C- did not occur anywhere else in the sequence
and since bases 103-118 were shown to be at the 5' end of the complemen-
tary strand by the 5' terminal labeling experiments, the following
sequence assignment was made:
2-103 8-108-110
5' -- T-T-A-A-A-T-A-G-C-T-T-G-C-A-A-A-A-T-A-C-G-T-G-G 3' end
100 110 viral strand
3' ------A-A-T-T-T-A-T-C-G-A-A-C-G-T-T-T-T-A-T-G-C-A-C-C 5' end
16-28-120-127 14-119 complemen-tary strand
DISCUSSION
The modified procedure described for the purification of T4 endo-
nuclease IV yields an enzyme preparation with a very low contaminating 3'
exonuclease activity. Examination of the sequences in Table I shows only
a very small number of oligonucleotides are identical except for the
absence of one or two bases at the 3' end. A previous study on RD1 A
34mitochondrial DNA supports this observation
The present results confirm that T4 endonuclease IV exhibits an
absolute specificity for the production of oligonucleotides ending in 5'
pCl9,32,35,36'37. Bernardi et al. 38 reported a lower 5' end specificity
which may be a function of their particular enzyme preparation. The
specificity of the nucleotides at the 3' end is not absolute. The dinucle-
otides T-C, G-C, A-C and C-C occur in the total sequence 15, 30, 25 and 23
times respectively. Comparison of these frequencies to those of each of
the four bases occurring at the 3' ends of the sequenced oligonucleotides
which were obtained in high yield, shows that T4 endonuclease IV exhibits
a preference for the cleavage of T-C and G-C bonds, over A-C bonds. The
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C-C bonds are cleaved very infrequently. These results are in good
agreement with previously published sequence data32'36'37.
The DNA sequencing method used does not require the DNA to be
uniformly 32P-labeled. The strand separation can be performed after
in vitro 32P-labeling of the purified restriction fragments and carrier
DNA or RNA is not required. After T4 endonuclease IV hydrolysis the
termini of the oligonucleotides can be labeled with polynucleotide kinase18
as in this study, or by terminal transferase39. The limiting factor in
the procedure is the strand separation which depends on the difference
in GT/AC content of the strands to be separated. Maniatis et al.37
separated the strands of two restriction fragments, 30 and 45 base pairs
in length, with 20% and 10% differences in GT content between the strands
respectively. The present study extends the electrophoretic separation
method to fragments 118 bases in length with 8% differences in GT content
between the strands.
Examination of the sequence reveals an AluI site at nucleotides
101-104 inclusive. The AZuI map of S13 RF DNA has not been determined.
The existence of a HindII site in HaeIII 87 is confirmed at positions 53-48
inclusive. Smith and Sinsheimer40 investigated the 5' end sequences of
in vitro transcription products from 4X174 RF DNA and reported that the
gene B transcript has the 5' end sequence AUCG(C). The transcript
hybridized to $X174 Hind fragment 811, which corresponds to S13 Hind
7fragment 6, which in turn overlaps S13 HaeIII 8 and 97. The sequence
ATCGC occurs twice in the HaeIII 8 and 9 sequence (Fig. 6) at nucleotides
84-88 and 140-144. A high degree of symmetry occurs in the sequence prior
to nucleotides 140-144 and there is also a sequence homologous to the
canonical promoter site sequence T-A-T-Pu-A-T-Pu41 at position 128-134.
Thus the region sequenced may contain the promoter site for the transcrip-
tion of gene B, assuming the 5' end of the S13 transcript is identical
to that from fX174.
The genetic maps of S13 and 4X174 are identical5 and the gene A
proteins of the two phages coelectrophorese on SDS gels and presumably are
the same size9. Since 4X174 HaeIII 9 and 10 map entirely in gene A42 and
correspond to S13 HaeIII 8 and 97 the two S13 fragments sequenced should
contain the genetic code for part of the S13 gene A protein. Examination
of the three possible reading frames in the viral sequence (Fig. 8)
reveals that two of the three frames contain stop codons. Nonsense trip-
lets occur at positions 49-51, 55-57,61-63 and 100-103 in one frame and
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at position 96-98 in the second. The amino acid sequence corresponding to
the third reading frame is presented in Fig. 8. Twenty-seven of the 67
GGC CGT CTT CAT TTC CAT GCG GTG CAT TTT ATG CGG ACA CTT CCT TCA
10
gly arg leu his phe his ala val his phe met arg thr leu pro ser
GGT AGC GTT GAC CCT AAC TTT GGT CGT CGG GTA CGC MAT CGC CGC CAG
20 30
gly ser val asp pro asn phe gly arg arg val arg asn arg arg gin
TTA AAT AGC TTG CM AAT ACG TGG CCT TAT GGT TAC AGT ATG CCC ATC
4 0
leu asn ser leu gin asn thr trp pro tyr gly tyr ser met pro ile
GCA GTT CGC TAC ACG CAG GAC GCT TTT TCA CGT TCT GGT TGG TTG TGG CCN
50 60
ala val arg tyr thr gin asp ala phe ser arg ser gly trp leu trp pro
Figure 8. The sequence of the viral strands of HaeIII 8 and 9 and
the postulated protein sequence of gene A protein.
The lines indicate nonsense codons (see text).
codons end in T, 15 in G, 15 in C and 7 in A. A similar unusual T
distribution was observed by Sanger43 in the codons in the F and G proteins
of 4X174 DNA. He suggested that the presence of U in the 3rd position
may have an advantageous effect in translation, a possibility first noted
by Denhardt and Marvin44. Other features of the predicted amino acid
sequence are the five proline residues occurring at amino acid positions
15, 21, 41, 47 and 65 (Fig. 8). These would tend to prevent helix
structure formation in this part of the protein molecule. Five arginine
residues occur in a 7 amino acid sequence stretch in positions 25-31. This
potentially highly-positively charged area of the protein is adjacent to a
neutral area due to the aspargine and glutamine residues at positions 29,
32, 34, 37 and 38. If the protein does not have any helical content (due
to the proline residues) the highly positively charged area would create a
very efficient site for DNA binding. The A protein has a nickase function
45 and therefore must have a DNA binding site located somewhere in its
structure. The unusual arginine distribution with its potential high
positive charge would be an excellent candidate for this DNA binding site.
ADDENDUM
Since the completion of this paper the sequence of 4X174 DNA has
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been reported46. The 4X174 sequence differs at positions 25, 44 and 64
(Fig. 6). The changes at 25 and 64 do not alter the predicted protein
sequence. The change at position 44 would result in a threonine in 4X174
instead of the serine in S13, a change which should not affect greatly the
structure or the function of the protein. These results are in accord with
1,92 ,3the similarities expected of the two DNA's in this area
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